Andersen CL, Mortensen NB, Klausen TW, Vestergaard H, Bjerrum OW, Hasselbalch HC. A phase II study of vorinostat (MK-0683) in patients with primary myelofibrosis and post-polycythemia vera myelofibrosis. Haematologica [Internet]. 2014Jan.14 [cited 2026Nov.15];99(1):e5-e7. Available from: https://haematologica.org/article/view/6914